» Articles » PMID: 36631877

Biochemical and Molecular Biomarkers: Unraveling Their Role in Gestational Diabetes Mellitus

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2023 Jan 11
PMID 36631877
Authors
Affiliations
Soon will be listed here.
Abstract

Gestational diabetes mellitus (GDM) is the most prevalent metabolic disorder during pregnancy, causing short- and long-term complications for both mother and baby. GDM is a multifactorial disease, and it may be affected by interactions between genetic, epigenetic, and environmental factors. However, the exact etiology is poorly understood. Despite the high prevalence of GDM, there is still debate regarding the optimal time for screening, the diagnostic threshold to apply, and the best strategies for treatment. Identifying effective strategies for therapeutic purposes as well as accurate biomarkers for prognostic and diagnostic purposes will reduce the GDM incidence and improve its management. In recent years, new biochemical and molecular biomarkers such as microRNAs, single-nucleotide polymorphisms, and DNA methylation have received great interest in the diagnosis of GDM. In this review, we discuss current and future diagnostic approaches for the detection of GDM and evaluate lifestyle and pharmacological strategies for GDM prevention.

Citing Articles

LncRNAs Involved in Antioxidant Response Regulation as Biomarkers of Gestational Diabetes: A Study on , and .

Stevanovic J, Petrovic U, Penezic A, Radojicic O, Ardalic D, Mandic M Antioxidants (Basel). 2025; 13(12.

PMID: 39765830 PMC: 11673377. DOI: 10.3390/antiox13121503.


Impact of Gestational Diabetes Mellitus on Fetal Growth and Nutritional Status in Newborns.

Karcz K, Krolak-Olejnik B Nutrients. 2024; 16(23).

PMID: 39683486 PMC: 11643953. DOI: 10.3390/nu16234093.


Predicting gestational diabetes mellitus risk at 11-13 weeks' gestation: the role of extrachromosomal circular DNA.

Wang J, Huang P, Hou F, Hao D, Li W, Jin H Cardiovasc Diabetol. 2024; 23(1):289.

PMID: 39113025 PMC: 11304788. DOI: 10.1186/s12933-024-02381-1.


Phenotypic characterisation of regulatory T cells in patients with gestational diabetes mellitus.

Zhang Y, Wu Q, Deng Y Sci Rep. 2024; 14(1):4881.

PMID: 38418860 PMC: 10902321. DOI: 10.1038/s41598-023-47638-z.


Genetic and Epigenetic Factors in Gestational Diabetes Mellitus Pathology.

Ustianowski L, Udzik J, Szostak J, Goracy A, Ustianowska K, Pawlik A Int J Mol Sci. 2023; 24(23).

PMID: 38068941 PMC: 10706782. DOI: 10.3390/ijms242316619.


References
1.
Alharbi K, Ali Khan I, Abotalib Z, Al-Hakeem M . Insulin receptor substrate-1 (IRS-1) Gly927Arg: correlation with gestational diabetes mellitus in Saudi women. Biomed Res Int. 2014; 2014:146495. PMC: 3948357. DOI: 10.1155/2014/146495. View

2.
Jamalpour S, Zain S, Mosavat M, Mohamed Z, Omar S . A case-control study and meta-analysis confirm glucokinase regulatory gene rs780094 is a risk factor for gestational diabetes mellitus. Gene. 2018; 650:34-40. DOI: 10.1016/j.gene.2018.01.091. View

3.
Choudhury A, Devi Rajeswari V . Gestational diabetes mellitus - A metabolic and reproductive disorder. Biomed Pharmacother. 2021; 143:112183. DOI: 10.1016/j.biopha.2021.112183. View

4.
Chu S, Callaghan W, Kim S, Schmid C, Lau J, England L . Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007; 30(8):2070-6. DOI: 10.2337/dc06-2559a. View

5.
Moses R, Wong V, Lambert K, Morris G, San Gil F . Seasonal Changes in the Prevalence of Gestational Diabetes Mellitus. Diabetes Care. 2016; 39(7):1218-21. DOI: 10.2337/dc16-0451. View